In the lead profile, Jansson represented those researchers investigating such diseases by using omics technologies - uncovering the DNA sequences, expressed genes, and
metabolite signatures used to reveal links to microbial functions in the gut.
«If we knock out, one by one, a wide range of genes of known function, and analyze proteins,
metabolites and lipids,
using the technology that Josh's group has developed, the data provide a «
signature» for what each protein is doing.